{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:00:18Z","timestamp":1780574418209,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"FWO"},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005293","name":"Harvard School of Public Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005293","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007319","name":"Albert Einstein College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VIB","award":["UZ \u2013 K"],"award-info":[{"award-number":["UZ \u2013 K"]}]},{"DOI":"10.13039\/100010905","name":"Illumina","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010905","id-type":"DOI","asserted-by":"crossref"}]},{"name":"VIB"},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["NR-14855"],"award-info":[{"award-number":["NR-14855"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.vaccine.2019.05.022","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T17:21:31Z","timestamp":1558372891000},"page":"3539-3551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["SapM mutation to improve the BCG vaccine: Genomic, transcriptomic and preclinical safety characterization"],"prefix":"10.1016","volume":"37","author":[{"given":"Nele","family":"Festjens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"Vandewalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Houthuys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Plets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Vanderschaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katlyn","family":"Borgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Van Hecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Tiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Callewaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.05.022_b0005","unstructured":"WHO | Global tuberculosis report 2018. WHO n.d. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"10.1016\/j.vaccine.2019.05.022_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00121","article-title":"Next-generation vaccines based on Bacille Calmette-Gu\u00e9rin","volume":"9","author":"Nieuwenhuizen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0015","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0020","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.vaccine.2019.05.022_b0025","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.05.022_b0030","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0015-2016","article-title":"Clinical testing of tuberculosis vaccine candidates","volume":"4","author":"Hatherill","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.022_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/s41479-016-0020-z","article-title":"Novel vaccination approaches to prevent tuberculosis in children","volume":"8","author":"Triccas","year":"2016","journal-title":"Pneumonia"},{"key":"10.1016\/j.vaccine.2019.05.022_b0040","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.022_b0045","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.022_b0050","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.022_b0055","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","article-title":"The protective effect of the mycobacterium bovis BCG vaccine is increased by coadministration with the mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs","volume":"72","author":"Brandt","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.022_b0060","doi-asserted-by":"crossref","first-page":"53ra74","DOI":"10.1126\/scitranslmed.3001094","article-title":"Defined tuberculosis vaccine candidate boosts bcg and protects against multidrug resistant mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2019.05.022_b0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/emmm.201000125","article-title":"Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis","volume":"3","author":"Festjens","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.vaccine.2019.05.022_b0070","doi-asserted-by":"crossref","first-page":"e70514","DOI":"10.1371\/journal.pone.0070514","article-title":"Secreted acid phosphatase (SapM) of Mycobacterium tuberculosis is indispensable for arresting phagosomal maturation and growth of the pathogen in guinea pig tissues","volume":"8","author":"Puri","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.022_b0075","article-title":"An attenuated quadruple gene mutant of Mycobacterium tuberculosis imparts protection against tuberculosis in guinea pigs","volume":"7","author":"Bahal","year":"2017","journal-title":"Biol Open"},{"key":"10.1016\/j.vaccine.2019.05.022_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007011","article-title":"The SecA2 pathway of Mycobacterium tuberculosis exports effectors that work in concert to arrest phagosome and autophagosome maturation","volume":"14","author":"Zulauf","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.05.022_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036198","article-title":"The fbpA\/sapM Double Knock Out Strain of Mycobacterium tuberculosis Is Highly Attenuated and Immunogenic in Macrophages","volume":"7","author":"Saikolappan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.022_b0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"Nunes-Alves","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5212910","article-title":"Role of interferons in the development of diagnostics, vaccines, and therapy for tuberculosis","volume":"2017","author":"Chin","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2019.05.022_b0100","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.4049\/jimmunol.171.9.4689","article-title":"CD4+ T cells mediate IFN-\u03b3-independent control of mycobacterium tuberculosis infection both in vitro and in vivo","volume":"171","author":"Cowley","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002052","article-title":"A Gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo","volume":"7","author":"Gallegos","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.05.022_b0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/infdis\/jiv055","article-title":"Interferon \u03b3 and tumor necrosis factor are not essential parameters of CD4+ T-cell responses for vaccine control of tuberculosis","volume":"212","author":"Orr","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.022_b0115","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/j.vaccine.2015.10.115","article-title":"Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy","volume":"33","author":"Orr","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.022_b0120","article-title":"Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression","volume":"1","author":"Sallin","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chom.2008.03.003","article-title":"Mycobacterium tuberculosis Prevents Inflammasome Activation","volume":"3","author":"Master","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2019.05.022_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8106","article-title":"Characterization of genome-wide ordered sequence-tagged Mycobacterium mutant libraries by Cartesian Pooling-Coordinate Sequencing","volume":"6","author":"Vandewalle","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2019.05.022_b0135","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1128\/JB.00257-07","article-title":"A genomic view of sugar transport in mycobacterium smegmatis and mycobacterium tuberculosis","volume":"189","author":"Titgemeyer","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","article-title":"Genes required for mycobacterial growth defined by high density mutagenesis","volume":"48","author":"Sassetti","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2005.02832.x","article-title":"Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant","volume":"141","author":"Infante","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0150","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JB.187.7.2267-2277.2005","article-title":"Transposon mutagenesis of Mb0100 at the ppe1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to those of M. bovis BCG","volume":"187","author":"Hotter","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0155","doi-asserted-by":"crossref","first-page":"e40063","DOI":"10.7554\/eLife.40063","article-title":"Mycobacterium tuberculosis SatS is a chaperone for the SecA2 protein export pathway","volume":"8","author":"Miller","year":"2019","journal-title":"ELife"},{"key":"10.1016\/j.vaccine.2019.05.022_b0160","doi-asserted-by":"crossref","first-page":"D499","DOI":"10.1093\/nar\/gkn652","article-title":"TB database: an integrated platform for tuberculosis research","volume":"37","author":"Reddy","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2019.05.022_b0165","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1128\/JB.182.23.6850-6853.2000","article-title":"Secretion of an acid phosphatase (SapM) by Mycobacterium tuberculosis that is similar to eukaryotic acid phosphatases","volume":"182","author":"Saleh","year":"2000","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0170","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.str.2005.07.017","article-title":"Mycobacterium tuberculosis protein tyrosine phosphatase PtpB structure reveals a diverged fold and a buried active site","volume":"13","author":"Grundner","year":"2005","journal-title":"Structure"},{"key":"10.1016\/j.vaccine.2019.05.022_b0175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0300985811429314","article-title":"Immunological variation between inbred laboratory mouse strains points to consider in phenotyping genetically immunomodified mice","volume":"49","author":"Sellers","year":"2012","journal-title":"Vet Pathol Online"},{"key":"10.1016\/j.vaccine.2019.05.022_b0180","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4049\/jimmunol.1002725","article-title":"Crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral Lymph node NK1.1\u2212 invariant NKT cells to Bacteria","volume":"186","author":"Doisne","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mi.2011.13","article-title":"Role of innate cytokines in mycobacterial infection","volume":"4","author":"Cooper","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0190","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.022_b0195","doi-asserted-by":"crossref","first-page":"8114","DOI":"10.1016\/j.vaccine.2007.09.041","article-title":"Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety","volume":"25","author":"Chen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.022_b0200","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1471-2164-9-413","article-title":"Novel genome polymorphisms in BCG vaccine strains and impact on efficacy","volume":"9","author":"Leung","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vaccine.2019.05.022_b0205","doi-asserted-by":"crossref","first-page":"44153","DOI":"10.1074\/jbc.M111.310037","article-title":"Lipid phenotype of two distinct subpopulations of Mycobacterium bovis Bacillus Calmette-Guerin Tokyo 172 substrain","volume":"286","author":"Naka","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2019.05.022_b0210","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.05.022_b0215","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.vaccine.2015.01.058","article-title":"Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis","volume":"33","author":"Sander","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.022_b0220","unstructured":"Results from Innovative Phase 2 Tuberculosis Vaccine Trial Offer Potential for New BCG Revaccination. Aeras n.d. http:\/\/www.aeras.org\/\/."},{"key":"10.1016\/j.vaccine.2019.05.022_b0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.chom.2018.06.004","article-title":"Mechanisms of M. tuberculosis immune evasion as challenges to TB vaccine design","volume":"24","author":"Ernst","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2019.05.022_b0230","doi-asserted-by":"crossref","DOI":"10.5772\/29651","article-title":"How mycobacterium tuberculosis manipulates innate and adaptive immunity \u2013 new views of an old topic","author":"Brighenti","year":"2012","journal-title":"Underst Tuberc - Anal Orig Mycobacterium Tuberc Pathog"},{"key":"10.1016\/j.vaccine.2019.05.022_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00461","article-title":"Trying to see the forest through the trees: deciphering the nature of memory immunity to mycobacterium tuberculosis","volume":"9","author":"Orme","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4419-6451-9_7","article-title":"CD8 T-cell memory differentiation during acute and chronic viral infections","volume":"684","author":"Kalia","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2019.05.022_b0245","first-page":"31","article-title":"Isolation of genomic DNA from mycobacteria","volume":"101","author":"Belisle","year":"1998","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"10.1016\/j.vaccine.2019.05.022_b0250","unstructured":"CLC bio. CLC bio Genomics Workbench - Manual n.d."},{"key":"10.1016\/j.vaccine.2019.05.022_b0255","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1574-6968.2000.tb09100.x","article-title":"Isolation of RNA from mycobacteria grown under in vitro and in vivo conditions","volume":"186","author":"Dietrich","year":"2000","journal-title":"FEMS Microbiol Lett"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930636X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930636X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:53Z","timestamp":1759401173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1930636X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":51,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0264410X1930636X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.022","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/486993","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SapM mutation to improve the BCG vaccine: Genomic, transcriptomic and preclinical safety characterization","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}